The Regulated Expression of Epstein—Barr Virus. III. Proteins Specified by EBV During the Lytic Cycle

References

1. Bayliss G. J., Nonoyama M. 1978; Mechanisms of infection with Epstein-Barr virus. III. The synthesis of proteins in superinfected Raji cells. Virology 87:204–207
   [Google Scholar]
2. Bayliss G. J., Wolf H. 1979; Immobilization of viable lymphoblastoid cells on solid supports. In Advances in Comparative Leukemia Research pp 381–382 Edited by Yohn D., Lapin B., Blakeslee J. New York: Elsevier;
   [Google Scholar]
3. Diehl V., Henle G., Henle W., Kohn G. 1969; Effect of a herpes group virus (EBV) on growth of peripheral leukocyte cultures. In Vitro 4:92–99
   [Google Scholar]
4. Gerber P., Whang-Peng J., Monroe J. H. 1969; Transformation and chromosome changes induced by Epstein-Barr virus in normal human leukocyte cultures. Proceedings of the National Academy of Sciences of the United States of America 63:740–747
   [Google Scholar]
5. Glaser R., Nonoyama M. 1974; Host cell regulation and induction of EBV. Journal of Virology 14:174–176
   [Google Scholar]
6. Hampar B., Lenoir G., Nonoyama M., Derge J. G., Chang S.-Y. 1976; Cell cycle dependence for activation of Epstein-Barr virus by inhibitors of protein synthesis or medium deficient in arginine. Virology 69:660–668
   [Google Scholar]
7. Henle G., Henle W. 1966; Immunofluorescence in cells derived from Burkitts lymphoma. Journal of Bacteriology 91:1248–1256
   [Google Scholar]
8. Henle W., Henle G., Zajac B. A., Pearson G., Waubke R., Scriba M. 1970; Differential reactivity of human sera with early antigens induced by Epstein-Barr virus. Science 169:188–190
   [Google Scholar]
9. Henle G., Henle W., Klein G. 1971; Demonstration of two distinct components in the early antigen complex of Epstein-Barr infected cells. International Journal of Cancer 8:272–282
   [Google Scholar]
10. Honess R. W., Roizman B. 1974; Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of 3 groups of viral polypeptides. Journal of Virology 14:8–19
    [Google Scholar]
11. Honess R. W., Roizman B. 1975; Regulation of herpesvirus macromolecular synthesis: sequential transition of polypeptide synthesis requires functional viral polypeptides. Proceedings of the National Academy of Sciences of the United States of America 72:1276–1280
    [Google Scholar]
12. Kallin B., Luka J., Klein O. 1979; Immunochemical characterization of Epstein-Barr virus associated early and late antigens in N-butyrate treated P3HR1 cells. Journal of Virology 32:710–716
    [Google Scholar]
13. Kessler S. W. 1975; Rapid isolation of antigens from cells with a staphylococcal protein-A antibody adsorbant: parameters of the interaction of antibody-antigen complexes with protein-A. Journal of Immunology 115:1617–1624
    [Google Scholar]
14. Luka J., Kallin B., Klein G. 1979; Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by N-butyrate. Virology 94:228–232
    [Google Scholar]
15. Mele J., Glaser R., Nonoyama M., Zimmermann J., Rapp F. 1974; Observation on the resistance of Epstein-Barr virus DNA synthesis to hydroxyurea. Virology 62:102–111
    [Google Scholar]
16. Miller G., Shope T., Lisco H., Stitt D., Lipman M. 1972; Epstein-Barr virus: transformation, cytopathic changes and viral antigens in squirrel monkey and marmoset leukocytes. Proceedings of the National Academy of Sciences of the United States of America 69:383–387
    [Google Scholar]
17. Mueller-Lantzsch N., Yamamoto N., Zur hausen H. 1979; Analysis of early and late Epstein-Barr virus associated polypeptides by immunoprecipitation. Virology 97:378–387
    [Google Scholar]
18. Rakusanova T., Ben-Porat T., Himeno M., Kaplan A. S. 1971; Early function of the genome of herpes virus.I. Characterization of the RNA synthesized in cycloheximide-treated, infected cells. Virology 46:877–889
    [Google Scholar]
19. Reedman B. M., Klein G. 1973; Cellular location of an Epstein-Barr virus (EBV) associated complement fixing antigen in producer and non-producer lymphoblastoid cell lines. International Journal of Cancer 11:499–520
    [Google Scholar]
20. Seigneurin J. M., Vuillaume M., Lenoir G., De The G. 1977; Replication of Epstein-Barr virus: ultra structural and immunofluorescent studies of P3HRl-superinfected Raji cells. Journal of Virology 24:836–845
    [Google Scholar]
21. Silvestre D., Kourilsky F. M., Klein G., Yata Y., Neauport-Santes C., Levy J. P. 1971; Relationship between the EBV associated membrane antigen on Burkitt lymphoma cells and the viral envelope demonstrated by immunoferritin labelling. International Journal of Cancer 8:222–233
    [Google Scholar]
22. Tanaka A., Nonoyama M. 1974; Latent DNA of Epstein-Barr virus: separation from high molecular weight cell DNA in neutral glycerol gradients. Proceedings of the National Academy of Sciences of the United States of America 71:4658–4661
    [Google Scholar]
23. Thorley-Lawson D. A. 1979; Characterization of cross reacting antigens on the Epstein-Barr virus envelope and plasma membranes of producer cells. Cell 16:33–42
    [Google Scholar]
24. Tovey M. G., Lenoir G., Begon-Lours J. 1978; Activation of latent Epstein-Barr virus by antibody to human IgM. Nature, London 276:270–272
    [Google Scholar]
25. Wolf H., Bayliss G. J. 1978; The role of host-virus interactions for the development of herpesvirus induced malignancies of New-World primates. In Antiviral Mechanisms in the Control of Neoplasia pp 315–329 Edited by Chandra P. New York: Plenum Press;
    [Google Scholar]
26. Wolf H., Roizman B. 1977; The regulation of γ (structural) polypeptide synthesis in herpes simplex virus types 1 and 2 infected cells. In Oncogenesis and Herpesvirus Ill/part 1 pp 327–336 Edited by de The G., Henle W., Rapp F. Lyon: IARC publication No. 24 part 1;
    [Google Scholar]
27. Yajima Y., Nonoyama M. 1976; Mechanisms of infection with Epstein-Barr virus. I. Viral DNA replication and formation of non-infectious particles in superinfected Raji cells. Journal of Virology 19:187–194
    [Google Scholar]
28. Yajima Y., Tanaka A., Nonoyama M. 1976; Inhibition of productive replication of Epstein-Barr virus by phosphonoacetic acid. Virology 71:353–354
    [Google Scholar]
29. Zur Hausen H., O’neill F. J., Freese U. K., Hecker E. 1978; Persisting oncogenic herpesvirus induced by the tumor promoter TPA. Nature, London 272:373–375
    [Google Scholar]